Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 946-947

  Meletis, Georgios ^a   Tzampaz, Egki ^a   Sianou, Effrosyni ^a   Tzavaras, Ioannis ^b   Sofianou, Danai ^a  

^a Aristotle University of Thessaloniki   (Greece)

^b NONE   (Greece)

Author keywords

K. Pneumoniae; KPC; VIM

Indexed keywords

CARBAPENEMASE; COLISTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM COLONY; BACTERIUM ISOLATE; DRUG TREATMENT FAILURE; HETERORESISTANCE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 79952807673     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr007     Document Type: Letter

References (9)

1. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
2. Tsakris A, Poulou A, Pournaras S et al. A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother 2010; 65: 1664-71.
3. Pournaras S, Protonotariou E, Voulgari E et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64: 348-52.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
5. European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 1.1 April 2010. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.1.pdf (5 December 2010, date last accessed).
6. Kontopoulou K, Protonotariou E, Vasilakos K et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin. J Hosp Infect 2010; 76: 70-3.
7. Zarkotou O, Pournaras S, Voulgari E et al. Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. J Clin Microbiol 2010; 48: 2271-4.
8. Poudyal A, Howden PB, Bell JM et al. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother 2008; 62: 1311-8.
9. Tan TY, Ng SY. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 2007; 13: 541-4.